This app is for sale. Asking price: $38,100
1.3x revenue
276 buyers have viewed this
1 offer made
Shotwise app icon

Shotwise

Wegovy, Ozempic, Mounjaro

Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.

Worldwide Release Date: January 9, 2025

Verified withRevenueCatFor Sale
#78 MRR
#82 Revenue
#36 in Health & Fitness
Transparency: 10/10

Star Ratings(129 ratings | avg ★ 4.6)

App Store (129 ratings)

us

4.7

106 ratings

gb

4.5

14 ratings

ca

5.0

4 ratings

nl

2.5

2 ratings

fr

5.0

1 rating

de

3.0

1 rating

br

5.0

1 rating

Last 28 days

Revenue

$2,403

AR

$28,836

MRR

$1,905

ARR

$22,860

Cash Flow Index

1.3x

Active Subscriptions

1,259

Active Trials

2

ARPAS

$1.91

Paid Subscriber Share (snapshot)

99.8%

Active Customers

769

New Customers

132

Subscription Penetration

163.7%

ARPU

$3.12

RPD

$3.12

ARPPU

$1.51

LTV

$5

MRR Growth (28d)

-15.4%

Revenue Growth (28d)

+64.9%

Subscriber Growth (28d)

-28.3%

All data is verified through RevenueCat. Last updated: Mar 16, 2026, 03:31:16 PM UTC.

App Screenshots

Shotwise screenshot 1
Shotwise screenshot 2
Shotwise screenshot 3
Shotwise screenshot 4
Shotwise screenshot 5

In-App Pricing

ShotWise Pro Annual$24.99
ShotWise Pro Annual$9.99
Shotwise Pro Annual$4.99

Tech Stack

Frontend
ExpoExpo

About This Listing

A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.

Asking Price

$38,100

Sale Details

Business Operations Started

Jan 2025

Assets Included in Sale

Social media accounts

Source Code Included

Yes

Post-Sales Support

Yes, seller will provide support
Privacy Policy|Terms of Service